Category

Knowledge

Ins and Outs of Clinical Trials: Publication Rights

By | Biotech, Knowledge, Life Sciences

Looking back to our last post in the Ins and Outs series on Confidentiality, you’ll see there’s an obvious disconnect and therefore potential conflict in relation to publication rights between a sponsor and the principal investigator (PI)/institution. Onerous restrictions on publication rights could be counterproductive and unlikely to be accepted by the institution and PI. For a start, it could potentially sour the goodwill and alliance established between the institution, PI and sponsor prior to commencing the clinical trial. Further, sponsors understand that for many institutions and PIs, in addition to facilitating the development of new medicines, conducting clinical trials has the allure…

Read More

Cross Border M&A Success

By | Biotech, Client news, Knowledge, Life Sciences, M&A

In Life Science news, Akarna Therapeutics Ltd. was acquired by Allergan plc (NYSE: AGN) for an upfront cash payment of $50 million. JAG Shaw Baker acted on behalf of New Science Ventures LLC, a New York venture capital fund that invests in novel scientific approaches. New Science Ventures was one of the selling shareholders alongside Third Point Ventures and Forbion Capital Partners. Akarna Therapeutics is a UK company with offices in Cambridge, UK and San Diego, California. Akarna Therapeutic’s lead product candidate (AKN-083) is considered an effective and novel treatment of non-alcoholic steatohepatitis (NASH) and other liver diseases. An M&A…

Read More

The Top Four Tips You Need to Prep For A Biotech IPO

By | Biotech, Current Affairs, Knowledge, Life Sciences, Partner Insight

Biotech companies have fared well recently in the IPO market in both the US and the UK. New legislation in the US has eased access to public markets and the AIM market in London continues to be attractive for emerging biotech companies. If you’re considering an IPO to raise capital for your biotech company, here are the four top tips you need to prep you on how to prepare for your big launch. 1. Intellectual property is key Wrap up any and all Intellectual Property (IP) issues before kicking off an IPO process. Most advisors and investors are not as…

Read More

Nick Crabtree Elevated To Partner

By | Brand, Current Affairs, Knowledge, M&A, Partner Insight, People

Today, we’re delighted to announce the elevation of Nick Crabtree to partner in our Corporate team. Nick is an influential member of the team at JAG Shaw Baker and since he joined the firm in early 2015, it’s remarkable to see how he’s helped the team deliver and close more than 200 transactions in that time. Nick has also been lead attorney on many key client mandates and has helped dozens of clients through successful M&A and investment transactions in the retail and technology markets – notably the sale of Fits.me to Rakuten and the sale of Wool and the…

Read More

A New Blog Series: The Ins And Outs Of Clinical Trials

By | Biotech, Knowledge, Life Sciences

In our new 10 part blog series on clinical trials, Sharmela Thevarajaha, Associate, Intellectual Property and Life Sciences, brings her wealth of private practice and in-house experience with clients such as Sanofi and Takeda, to take a look at some key clauses within a sponsor-initiated clinical trial agreement. In the series she highlights the crucial legal, ethical and business issues to consider when negotiating these key provisions including payments, intellectual property, insurance and publication rights. ______ Clinical research collaboration plays a significant role in developing medicines, advancing medical knowledge and enhancing patient care.   Without clinical trials, pharmaceutical companies (the…

Read More

The Privacy Shield Has Arrived

By | Current Affairs, Data & Privacy, Investor and VC News, Knowledge

It’s finally here! The EU – U.S. Privacy Shield (aka Safe Harbour 2.0) has been approved by the European Commission which means businesses in the EU will be able to transfer personal data to U.S. self-certified companies without the need for any further safeguards. There’s been an air of uncertainty around personal data transfers between the EU and the U.S. since the European Court of Justice (ECJ) invalidated the Safe Harbour scheme in October 2015; so this is great news for businesses in the EU which use service providers based in the U.S. Rather than discussing the background of the…

Read More

The Effect Of Brexit On Venture Investing

By | Brand, Current Affairs, Entrepreneurs, Investor and VC News, Knowledge, Partner Insight

The Brexit Referendum has come and gone but has left a legacy of conversation and debate in the UK and around the world. From education and trade issues to tourism and technology, Brexit has been talked about a great deal (probably too much!) over the last two weeks. As a law firm at the heart of the UK’s thriving technology and life science sectors, we have experienced firsthand the concerns of entrepreneurs and investors alike. We wanted to candidly share our views on what we’re seeing as effects of Brexit vote – and what we therefore might expect to see – in…

Read More

The PSC Register – What’s It All About?

By | Documentation, Knowledge

On 26 March 2015, the UK Government enacted The Small Business, Employment and Enterprise Act (the Act) to enhance ownership transparency and increase trust in UK businesses. One of the key changes to UK companies is the register of people with Significant Control (PSC) which came into force on 6 April 2016. The Act requires all UK private companies to identify its PSCs, and to hold and maintain a PSC register in addition to existing statutory registers. What does this mean for you? If you are a director or responsible for maintaining the registers, you will need to take the following steps:…

Read More

A cookie is a small file of letters and numbers that we store on your browser or computer, phone or tablet hard drive if you agree. more information

INFORMATION ABOUT OUR USE OF COOKIES Our website uses cookies to distinguish you from other users of our website. This helps us to provide you with a good experience and also allows us to improve our website. By continuing to browse the website, you are agreeing to our use of cookies. A cookie is a small file of letters and numbers that we store on your browser or computer, phone or tablet hard drive if you agree. We use the following cookies: • Strictly necessary cookies. These are cookies that are required for the operation of our website. They include, for example, cookies that enable you to return to a previous page. • Analytical/performance cookies. They allow us to recognise and count the number of visitors and to see how visitors move around our website when they are using it. This helps us to improve the way our website works, for example, by ensuring that users are finding what they are looking for easily. The analytical/performance cookies are provided on our behalf by Google Inc. to aid with reporting of user behaviour, market research and improving website functionality. This user behaviour is analysed in order to improve this website. To see how this applies to Google Analytics, visit http://www.google.co.uk/intl/en/analytics/privacyoverview.html. You can stop tracking by Google Analytics by visiting https://tools.google.com/dlpage/gaoptout?hl=en-GB. COOKIE DURATION The strictly necessary session cookies are a temporary cookie which remains in the cookie file of your browser until you close the browser. The other cookies will remain in the cookie file of your browser after the closing of the browser, and will become active again when you reopen this website. The different cookies have different expiration dates. Following expiry of a cookie, a new version of that cookie will be downloaded when you next visit this website, unless you have withdrawn your consent in the meantime. You can block cookies by activating the setting on your browser that allows you to refuse the setting of all or some cookies. However, if you use your browser settings to block all cookies (including essential cookies) you may not be able to access all or parts of our website. Contact If you have any queries regarding this cookie policy please contact us at info@jagshawbaker.com.

Close